Chamomile Tea for Anti-Inflammatory

Research suggests that chamomile and several of its key bioactive compounds — particularly apigenin, luteolin, quercetin, and lupeol — demonstrate anti-inflammatory properties across a range of laboratory and computational studies, with mechanisms including inhibition of NF-κB signaling, suppression of pro-inflammatory cytokines like IL-6 and TNF-α, and activation of antioxidant defense pathways. The available evidence comes predominantly from in vitro cell studies, animal experiments, and review articles synthesizing preclinical findings, with one 2006 dermatology review noting mixed results for chamomile in the context of rosacea and cautioning that some herbal ingredients may worsen certain inflammatory skin conditions. Studies indicate that specific compounds found in chamomile tea, such as luteolin and apigenin, show particular promise for reducing inflammation associated with high blood sugar, neonatal brain injury models, and gastrointestinal conditions, though all of these findings are preclinical in nature and have not been confirmed in human clinical trials. The body of evidence is supportive in its general direction but remains limited by a near-complete absence of randomized controlled trials or large-scale human studies, meaning that while the mechanistic rationale is increasingly well-characterized in laboratory settings, conclusions about real-world anti-inflammatory effects from drinking chamomile tea cannot yet be drawn with confidence.